Opsonix

Baxter, Harvard launch Opsonix

Friday, October 9, 2015

Cambridge, Mass.-based Opsonix has launched with an $8 million Series A financing to develop a pathogen-extracting therapy designed to remove infectious pathogens and toxins from circulating blood.

[Read More]